Home › Acute Kidney Injury › Pennsylvania › Pittsburgh
Acute Kidney Injury clinical trials in Pittsburgh, PA
5 studies for Acute Kidney Injury are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
RecruitingPhase 2
- Research Site, Pittsburgh
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
RecruitingPhase 2
- University of Pittsburgh, Pittsburgh
- Hillman Cancer Center, Pittsburgh
POCUS-Guided Diuresis for Decompensated Heart Failure
Recruiting
- UPMC East, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- UPMC Presbyterian, Pittsburgh
- and 2 more
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
RecruitingPhase 2/3
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Recruiting
- University of Pittsburgh Medical Center, Pittsburgh
Acute Kidney Injury trials in other cities
- Birmingham, AL8 studies
- Cincinnati, OH8 studies
- San Francisco, CA7 studies
- Durham, NC7 studies
- Ann Arbor, MI7 studies
- Baltimore, MD7 studies
- Dallas, TX7 studies
- New York City, NY6 studies
- Cleveland, OH6 studies
- Houston, TX5 studies
- Atlanta, GA5 studies
- Charleston, SC5 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Prostate Cancer23 studies
- Lung Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.